Global Cell Line DevelopmentMarket size is expected to
reach USD 6.24 billion by 2022, according to a new report by Grand View
Research, Inc. The Increasing demand for monoclonal antibodies and patent
expiration of blockbuster biologics are expected to drive the cell line
development industry over the forecast period.
Increasing prevalence of autoimmune
diseases and cancer are likely to increase the demand for accurate and cost
effective treatment options which is expected to render a positive impact on
market growth. In addition, improving healthcare infrastructure, economic
development and favorable government initiatives promoting the growth of the
biotechnology industry are factors contributing towards the growth of the cell
line development market.
Ongoing R&D for stable & authentic
cell lines and the introduction of technologically advanced processes such as
single use bioreactor and micro bioreactor for large scale bioproduction are
further expected to provide this market with lucrative future growth
opportunities.
Full Research Report On Global Cell Line
Development Market Analysis:
http://www.grandviewresearch.com/industry-analysis/cell-line-development-market
http://www.grandviewresearch.com/industry-analysis/cell-line-development-market
Further key findings from the study
suggest:
- Reagent and media was the largest product market in 2014, owing
to increasing number of cell culture procedures. Reagent and media are
necessary components involved in cell line development procedures &
cell culture and are cost intensive in nature. The market for reagent and
media was valued at over 1.0 billion in 2014.
- Mammalian cell lines were widely used as a source for cell line
development in 2014, owing to associated advantages such as accurate
complex protein expression nature, critical for the production of
monoclonal antibodies, vaccines, and biologics.
- Cell line development finds the largest application in the
bioproduction of biologics, vaccines, Mabs, therapeutic proteins and
biosimilars. Rising demand for monoclonal antibodies and vaccines are
expected to boost the growth of this segment over the forecast period. The
market for cell line development based bioproduction is also expected to
witness lucrative growth of over 12.5% during the forecast period.
- North America was the largest market in 2014, with revenue
estimated at over 800 million. The region’s market dominance is attributed
to factors such as the growing adoption rates of cell culture techniques,
presence of well developed healthcare infrastructure, supportive
government initiatives and high healthcare expenditure levels.
- Asia Pacific cell line development market is anticipated to
register rapid growth over the forecast period owing to factors such as
the presence of high unmet needs, rising number of CROs (Contract Research
Organization) providing pertinent services, growing R&D investments
aimed at the development of stable cell lines and increasing biologics
production.
- Key players in this market include European Collection of cell
Cultures (ECACC), Lonza Group AG, GE Healthcare, Thermo Fisher Scientific
Inc., Sartorious AG, Selexis SA, Wuxi AppTec Inc., Sigma-Aldrich
Corporation, American Type Culture Collection (ATCC) and Corning
Inc.
View
more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics
For
the purpose of this study, Grand View Research has segmented the Global Cell
Line Development Market on the basis of product, source, type of cell line,
application and region:
Global Cell Line Development Product
Outlook (Revenue, USD Million, 2012 - 2022)
·
Reagents and media
·
Equipment Accessories and
consumables
§ Incubators
§ Centrifuges
§ Bioreactors
§ Storage equipment
§ Microscopes
Global Cell Line Development Source
Outlook (Revenue, USD Million, 2012 - 2022)
·
Mammalian
·
Non mammalian
§ Insects
§ Amphibians
Global Cell Line Development Type Of
Cell Line Outlook (Revenue, USD Million, 2012 - 2022)
·
Recombinant cell lines
·
Hybridomas
·
Continuous cell line
·
Primary cell lines
Global Cell Line Development Application
Outlook (Revenue, USD Million, 2012 - 2022)
·
Bioproduction
·
Drug discovery
·
Toxicity testing
·
Tissue engineering
·
Research
Cell Line Development Regional Outlook
(Revenue, USD Billion, 2014 - 2022)
·
North America
§ U.S.
§ Canada
·
Europe
§ Germany
§ UK
·
Asia Pacific
§ China
§ Japan
§ India
·
Latin America
§ Mexico
§ Brazil
·
MEA
§ South Africa
View Press Release of this research report
by Grand View Research: http://www.grandviewresearch.com/press-release/global-cell-line-development-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment